Application Nr Approved Date Route Status External Links
ANDA079013 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Alfuzosin Hydrochloride Extended-Release Tablets, Usp Are Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. Alfuzosin Hydrochloride Extended-Release Tablet Is An Alpha Adrenergic Antagonist, Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. (1) Important Limitations Of Use: Alfuzosin Hydrochloride Extended-Release Tablets Are Not Indicated For Treatment Of Hypertension. ( 1.1 ) Alfuzosin Hydrochloride Extended-Release Tablets Are Not Indicated For Use In The Pediatric Population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations Of Use Alfuzosin Hydrochloride Extended-Release Tablets, Usp Are Not Indicated For The Treatment Of Hypertension. Alfuzosin Hydrochloride Extended-Release Tablets, Usp Are Not Indicated For Use In The Pediatric Population.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alfuzosin Hydrochloride ALFUZOSIN HYDROCHLORIDE ZINC1542392

Comments